| Muthusamy AS, Vaidya AC, Sinha S, et al.
Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation. [Journal Article]
Am J Transplant 2008 Oct; 8(10):2126-31.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Agarwal A, Shen LY, Kirk AD
The role of alemtuzumab in facilitating maintenance immunosuppression minimization following solid organ transplantation. [JOURNAL ARTICLE]
Transpl Immunol 2008 Sep 26.
Abstract | Full Citation | Find Related Articles |
| Tomillero A, Moral MA
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2008 Jun; 30(5):383-408.
Abstract | Full Citation |
| Lim ZY, Cook G, Johnson PR, et al.
Results of a phase I/II British Society of Bone Marrow Transplantation study on PCR-based pre-emptive therapy with valganciclovir or ganciclovir for active CMV infection following alemtuzumab-based reduced intensity allogeneic stem cell transplantation. [JOURNAL ARTICLE]
Leuk Res 2008 Sep 19.
Abstract | Full Citation |
| Toyoda Y, Thacker J, Santos R, et al.
Long-term outcome of lung and heart-lung transplantation for idiopathic pulmonary arterial hypertension. [Journal Article]
Ann Thorac Surg 2008 Oct; 86(4):1116-22.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Linker RA, Kieseier BC, Gold R
Identification and development of new therapeutics for multiple sclerosis. [JOURNAL ARTICLE]
Trends Pharmacol Sci 2008 Sep 17.
Abstract | Full Citation |
| Orlandi EM, Baldanti F, Citro A, et al.
Monitoring for cytomegalovirus and Epstein-Barr virus infection in chronic lymphocytic leukemia patients receiving i.v. fludarabine-cyclophosphamide combination and alemtuzumab as consolidation therapy. [JOURNAL ARTICLE]
Haematologica 2008 Sep 11.
Full Citation | Publisher Full Text | Find Related Articles |
| Kim H, Min YJ, Baek JH, et al.
A pilot dose-escalating study of alemtuzumab plus cyclosporine for patients with bone marrow failure syndrome. [JOURNAL ARTICLE]
Leuk Res 2008 Sep 12.
Abstract | Full Citation | Find Related Articles |
| Muñoz AS, Cabanayan-Casasola CB, Danguilan RA, et al.
Campath-1H (Alemtuzumab) as an Induction Agent for the Prevention of Graft Rejection and Preservation of Renal Function in Kidney Transplant Patients: Philippine 3-Year Follow-up. [Journal Article]
Transplant Proc 2008 Sep; 40(7):2230-3.
Abstract | Full Citation |
| Ona ET, Danguilan RA, Africa J, et al.
Use of Alemtuzumab (Campath-1H) as Induction Therapy in Pediatric Kidney Transplantation. [Journal Article]
Transplant Proc 2008 Sep; 40(7):2226-9.
Abstract | Full Citation | Find Related Articles |
  |
